Experiment 68730

Compounds isolated

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismEmpty organism
CitationMOYAD,MA: PIENTA,KJ: MONTIE,JE:. (1999). USE OF PC-SPES, A COMMERCIALLY AVAILABILE SUPPLEMENT FOR PROSTATE CANCER, IN A PATIENT WITH HORMONE-NAIVE DISEASE.. 54(2)
Amount utilized
Compound isolated
DiseaseIN A 63-YEAR-OLD WHITE MAN WITH PROSTATE CANCER, THE OVERALL CLINICAL BENEFITS, COST, AND SIDE EFFECTS ARE DRESENTED.
Dose amountVAR
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Dose expressionDOSE
GenderMALE